Translational research

Last updated

Translational research (also called translation research, translational science, or, when the context is clear, simply translation) [1] [2] is research aimed at translating (converting) results in basic research into results that directly benefit humans. The term is used in science and technology, especially in biology and medical science. As such, translational research forms a subset of applied research.

Contents

The term has been used most commonly in life sciences and biotechnology, but applies across the spectrum of science and humanities. In the context of biomedicine, translational research is also known as bench to bedside. [3] In the field of education, it is defined as research which translates concepts to classroom practice.

Critics of translational medical research (to the exclusion of more basic research) point to examples of important drugs that arose from fortuitous discoveries in the course of basic research such as penicillin and benzodiazepines. Other problems have stemmed from the widespread irreproducibility thought to exist in translational research literature.

Although translational research is relatively new, there are now several major research centers focused on it. In the U.S., the National Institutes of Health has implemented a major national initiative to leverage existing academic health center infrastructure through the Clinical and Translational Science Awards. Furthermore, some universities acknowledge translational research as its own field in which to study for a PhD or graduate certificate.

Definitions

Translational research is aimed at solving particular problems; the term has been used most commonly in life sciences and biotechnology, but applies across the spectrum of science and humanities.[ citation needed ]

In the field of education, it is defined for school-based education by the Education Futures Collaboration (www.meshguides.org) as research which translates concepts to classroom practice. [4] Examples of translational research are commonly found in education subject association journals and in the MESHGuides which have been designed for this purpose. [5]

In bioscience, translational research is a term often used interchangeably with translational medicine or translational science or bench to bedside. The adjective "translational" refers to the "translation" (the term derives from the Latin for "carrying over") of basic scientific findings in a laboratory setting into potential treatments for disease. [6] [7] [8] [9]

Biomedical translational research adopts a scientific investigation/enquiry into a given problem facing medical/health practices: [10] it aims to "translate" findings in fundamental research into practice. In the field of biomedicine, it is often called "translational medicine", defined by the European Society for Translational Medicine (EUSTM) as "an interdisciplinary branch of the biomedical field supported by three main pillars: benchside, bedside and community", [11] from laboratory experiments through clinical trials, to therapies, [12] to point-of-care patient applications. [13] The end point of translational research in medicine is the production of a promising new treatment that can be used clinically. [6] Translational research is conceived due to the elongated time often taken to bring to bear discovered medical idea in practical terms in a health system.[ citation needed ] It is for these reasons that translational research is more effective in dedicated university science departments or isolated, dedicated research centers. [14] Since 2009, the field has had specialized journals, the American Journal of Translational Research and Translational Research dedicated to translational research and its findings.

Translational research in biomedicine is broken down into different stages. In a two-stage model, T1 research, refers to the "bench-to-bedside" enterprise of translating knowledge from the basic sciences into the development of new treatments and T2 research refers to translating the findings from clinical trials into everyday practice, although this model is actually referring to the 2 "roadblocks" T1 and T2. [6] Waldman et al. [15] propose a scheme going from T0 to T5. T0 is laboratory (before human) research. In T1-translation, new laboratory discoveries are first translated to human application, which includes phase I & II clinical trials. In T2-translation, candidate health applications progress through clinical development to engender the evidence base for integration into clinical practice guidelines. This includes phase III clinical trials. In T3-translation, dissemination into community practices happens. T4-translation seeks to (1) advance scientific knowledge to paradigms of disease prevention, and (2) move health practices established in T3 into population health impact. Finally, T5-translation focuses on improving the wellness of populations by reforming suboptimal social structures

Comparison to basic research or applied research

Basic research is the systematic study directed toward greater knowledge or understanding of the fundamental aspects of phenomena and is performed without thought of practical ends. It results in general knowledge and understanding of nature and its laws. [16] For instance, basic biomedical research focuses on studies of disease processes using, for example, cell cultures or animal models without consideration of the potential utility of that information. [11]

Applied research is a form of systematic inquiry involving the practical application of science. It accesses and uses the research communities' accumulated theories, knowledge, methods, and techniques, for a specific, often state, business, or client-driven purpose. [17] Translational research forms a subset of applied research. In life-sciences, this was evidenced by a citation pattern between the applied and basic sides in cancer research that appeared around 2000. [18] In fields such as psychology, translational research is seen as a bridging between applied research and basic research types. The field of psychology defines translational research as the use of basic research to develop and test applications, such as treatment.

Challenges and criticisms

Critics of translational medical research (to the exclusion of more basic research) point to examples of important drugs that arose from fortuitous discoveries in the course of basic research such as penicillin and benzodiazepines, [19] and the importance of basic research in improving our understanding of basic biological facts (e.g. the function and structure of DNA) that go on to transform applied medical research. [20] Examples of failed translational research in the pharmaceutical industry include the failure of anti-aβ therapeutics in Alzheimer's disease. [21] Other problems have stemmed from the widespread irreproducibility thought to exist in translational research literature. [22]

Translational research-facilities in life-sciences

Translational Research Institute, Woolloongabba Translational Research Institute, Wooloongabba.jpg
Translational Research Institute, Woolloongabba

In U.S., the National Institutes of Health has implemented a major national initiative to leverage existing academic health center infrastructure through the Clinical and Translational Science Awards. The National Center for Advancing Translational Sciences (NCATS) was established on December 23, 2011. [23]

Although translational research is relatively new, it is being recognized and embraced globally. Some major centers for translational research include:

Additionally, translational research is now acknowledged by some universities as a dedicated field to study a PhD or graduate certificate in, in a medical context. These institutes currently include Monash University in Victoria, Australia, [33] the University of Queensland, Diamantina Institute in Brisbane, Australia, [34] at Duke University in Durham, North Carolina, America, [35] at Creighton University in Omaha, Nebraska [36] at Emory University in Atlanta, Georgia, [37] and at [38] The George Washington University in Washington, D.C. The industry and academic interactions to promote translational science initiatives has been carried out by various global centers such as European Commission, GlaxoSmithKline and Novartis Institute for Biomedical Research. [39]

See also

Related Research Articles

Evidence-based medicine (EBM) is "the conscientious, explicit and judicious use of current best evidence in making decisions about the care of individual patients. ... [It] means integrating individual clinical expertise with the best available external clinical evidence from systematic research." The aim of EBM is to integrate the experience of the clinician, the values of the patient, and the best available scientific information to guide decision-making about clinical management. The term was originally used to describe an approach to teaching the practice of medicine and improving decisions by individual physicians about individual patients.

<span class="mw-page-title-main">Health informatics</span> Computational approaches to health care

Health informatics is the study and implementation of computer structures and algorithms to improve communication, understanding, and management of medical information. It can be viewed as a branch of engineering and applied science.

<span class="mw-page-title-main">Medical research</span> Wide array of research

Medical research, also known as health research, refers to the process of using scientific methods with the aim to produce knowledge about human diseases, the prevention and treatment of illness, and the promotion of health.

The Doctor of Medicine–Doctor of Philosophy (MD–PhD) is a dual doctoral program for physician–scientists, combining the professional training of the Doctor of Medicine degree with the research program of the Doctor of Philosophy degree.

Translational medicine develops the clinical practice applications of the basic science aspects of the biomedical sciences; that is, it translates basic science to applied science in medical practice. It is defined by the European Society for Translational Medicine as "an interdisciplinary branch of the biomedical field supported by three main pillars: benchside, bedside, and community". The goal of translational medicine is to combine disciplines, resources, expertise, and techniques within these pillars to promote enhancements in prevention, diagnosis, and therapies. Accordingly, translational medicine is a highly interdisciplinary field, the primary goal of which is to coalesce assets of various natures within the individual pillars in order to improve the global healthcare system significantly.

<span class="mw-page-title-main">University of Pittsburgh School of Medicine</span> Medical school in Pittsburgh, Pennsylvania, US

The University of Pittsburgh School of Medicine is a medical school of the University of Pittsburgh, located in Pittsburgh, Pennsylvania. The School of Medicine, also known as Pitt Med, encompasses both a medical program, offering the doctor of medicine, and graduate programs, offering doctor of philosophy and master's degrees in several areas of biomedical science, clinical research, medical education, and medical informatics.

Evidence-based practice is the idea that occupational practices ought to be based on scientific evidence. The movement towards evidence-based practices attempts to encourage and, in some instances, require professionals and other decision-makers to pay more attention to evidence to inform their decision-making. The goal of evidence-based practice is to eliminate unsound or outdated practices in favor of more-effective ones by shifting the basis for decision making from tradition, intuition, and unsystematic experience to firmly grounded scientific research. The proposal has been controversial, with some arguing that results may not specialize to individuals as well as traditional practices.

<span class="mw-page-title-main">Wake Forest School of Medicine</span> Medical school of Wake Forest University

Wake Forest University School of Medicine is the medical school of Wake Forest University, with two campuses located in Winston-Salem, North Carolina and Charlotte, North Carolina, United States. It is affiliated with Atrium Health Wake Forest Baptist, the academic medical center whose clinical arm is Atrium Health Wake Forest Baptist. In 2021, U.S. News & World Report ranked Wake Forest School of Medicine 48th best for research in the nation and 80th best for primary care. The School of Medicine also ranks in the top third of U.S. medical schools in funding from the National Institutes of Health (NIH).

David Lawrence Sackett was an American-Canadian physician and a pioneer in evidence-based medicine. He is known as one of the fathers of Evidence-Based Medicine. He founded the first department of clinical epidemiology in Canada at McMaster University, and the Oxford Centre for Evidence-Based Medicine. He is well known for his textbooks Clinical Epidemiology and Evidence-Based Medicine.

Edward ("Ted") Hance Shortliffe is a Canadian-born American biomedical informatician, physician, and computer scientist. Shortliffe is a pioneer in the use of artificial intelligence in medicine. He was the principal developer of the clinical expert system MYCIN, one of the first rule-based artificial intelligence expert systems, which obtained clinical data interactively from a physician user and was used to diagnose and recommend treatment for severe infections. While never used in practice, its performance was shown to be comparable to and sometimes more accurate than that of Stanford infectious disease faculty. This spurred the development of a wide range of activity in the development of rule-based expert systems, knowledge representation, belief nets and other areas, and its design greatly influenced the subsequent development of computing in medicine.

<span class="mw-page-title-main">Narrative medicine</span> Medical approach

Narrative medicine is the discipline of applying the skills used in analyzing literature to interviewing patients. The premise of narrative medicine is that how a patient speaks about his or her illness or complaint is analogous to how literature offers a plot with characters and is filled with metaphors, and that becoming conversant with the elements of literature facilitates understanding the stories that patients bring. Narrative Medicine is a diagnostic and comprehensive approach that utilizes patients' narratives in clinical practice, research, and education to promote healing. Beyond attempts to reach accurate diagnoses, it aims to address the relational and psychological dimensions that occur in tandem with physical illness. Narrative medicine aims not only to validate the experience of the patient, it also encourages creativity and self-reflection in the physician.

<span class="mw-page-title-main">Max Delbrück Center for Molecular Medicine in the Helmholtz Association</span>

The Max Delbrück Center for Molecular Medicine in the Helmholtz Association in Berlin is one of the 18 institutions that make up the Helmholtz Association. It combines basic molecular biology research with clinical research and is dedicated to the research foci of systems medicine and cardiovascular diseases. The research center is named after the Berlin-born biophysicist and Nobel laureate Max Delbrück. The center is headed by Maike Sander.

The National Institute for Health and Care Research (NIHR) is the British government's major funder of clinical, public health, social care and translational research. With a budget of over £1.2 billion in 2020–21, its mission is to "improve the health and wealth of the nation through research". The NIHR was established in 2006 under the government's Best Research for Best Health strategy, and is funded by the Department of Health and Social Care. As a research funder and research partner of the NHS, public health and social care, the NIHR complements the work of the Medical Research Council. NIHR focuses on translational research, clinical research and applied health and social care research.

The Improvement Science Research Network (ISRN) is a research network for academics and physicians who are conducting studies in the new medical field of improvement science.

Basic research, also called pure research, fundamental research, basic science, or pure science, is a type of scientific research with the aim of improving scientific theories for better understanding and prediction of natural or other phenomena. In contrast, applied research uses scientific theories to develop technology or techniques, which can be used to intervene and alter natural or other phenomena. Though often driven simply by curiosity, basic research often fuels the technological innovations of applied science. The two aims are often practiced simultaneously in coordinated research and development.

<span class="mw-page-title-main">Mark Siegler</span> American physician

Mark Siegler is an American physician who specializes in internal medicine. He is the Lindy Bergman Distinguished Service Professor of Medicine and Surgery at the University of Chicago. He is the Founding Director of Chicago's MacLean Center for Clinical Medical Ethics. Siegler has practiced and taught internal medicine at the University of Chicago for more than 50 years.

Translational bioinformatics (TBI) is a field that emerged in the 2010s to study health informatics, focused on the convergence of molecular bioinformatics, biostatistics, statistical genetics and clinical informatics. Its focus is on applying informatics methodology to the increasing amount of biomedical and genomic data to formulate knowledge and medical tools, which can be utilized by scientists, clinicians, and patients. Furthermore, it involves applying biomedical research to improve human health through the use of computer-based information system. TBI employs data mining and analyzing biomedical informatics in order to generate clinical knowledge for application. Clinical knowledge includes finding similarities in patient populations, interpreting biological information to suggest therapy treatments and predict health outcomes.

Ellen Wright Clayton is an American academic specialzing in law and medicine. She is the Rosalind E. Franklin Professor of Genetics at Vanderbilt University and chairwoman of the Institute of Medicine Board at the Population Health and Public Health Practice. She was the 2013 recipient of the David Rall Medal.

A physician-scientist or clinician-scientist is a physician who divides their professional time between direct clinical practice with patients and scientific research. Physician-scientists traditionally hold both a medical degree and a doctor of philosophy, also known as an MD-PhD. Compared to other clinicians, physician-scientists invest significant time and professional effort in scientific research, with ratios of research to clinical time ranging from 50/50 to 80/20.

<span class="mw-page-title-main">Virginia Tech Carilion School of Medicine and Research Institute</span> Medical school at Virginia Tech University

The Virginia Tech Carilion School of Medicine is a public medical school of Virginia Tech and located in Roanoke, Virginia. The medical school is associated with the Fralin Biomedical Research Institute. Formed as a public–private partnership with the Carilion Clinic, the medical school grants the Doctor of Medicine (M.D.) degree to its graduates. Initially a private institution from 2008 to 2018, the medical school became an official college of Virginia Tech in 2018.

References

  1. ↑ "Translation Research | NIOSH | CDC". www.cdc.gov. 2020-02-24. Retrieved 2021-11-05.
  2. ↑ "What is Translational Research? | UAMS Translational Research Institute". tri.uams.edu. Retrieved 2021-11-05.
  3. ↑ Chawla, Bhavna (2018-08-03). "Bench to Bedside: Translational Research Demystified". The Official Scientific Journal of Delhi Ophthalmological Society. 29 (1): 4–5. doi: 10.7869/djo.367 . S2CID   81524567.
  4. ↑ Burden K, Younie S, Leask M (October 2013). "Translational research principles applied to education: the mapping educational specialist knowhow (MESH) initiative" (PDF). Journal of Education for Teaching. 39 (4): 459–463. doi:10.1080/02607476.2013.801216. S2CID   145145150.
  5. ↑ Younie S (2016). "Mapping Educational Specialist knowHow (MESH)". International Teacher Education Knowledge Mobilisation Summit: a framework for UNESCO SDG4 2030. London: Whitehall.
  6. 1 2 3 Woolf SH (January 2008). "The meaning of translational research and why it matters". JAMA. 299 (2): 211–3. doi:10.1001/jama.2007.26. PMID   18182604.
  7. ↑ Reis SE, Berglund L, Bernard GR, Califf RM, Fitzgerald GA, Johnson PC (March 2010). "Reengineering the national clinical and translational research enterprise: the strategic plan of the National Clinical and Translational Science Awards Consortium". Academic Medicine. 85 (3): 463–9. doi:10.1097/acm.0b013e3181ccc877. PMC   2829722 . PMID   20182119.
  8. ↑ Science Careers Staff (2011). "Careers in Clinical and Translational Research". Science. Retrieved March 24, 2018.
  9. ↑ Agency for Healthcare Research and Quality (2017). "Translating Research Into Practice". www.ahrq.gov. Retrieved March 25, 2018.
  10. ↑ Akarowhe K (2018) Translational Research: Definitions and Relevance. J Biol Med Res Vol.2 No.2:13
  11. 1 2 Cohrs RJ, Martin T, Ghahramani P, Bidaut L, Higgins PJ, Shahzad A (2014). "Translational Medicine definition by the European Society for Translational Medicine". New Horizons in Translational Medicine. 2 (3): 86–88. doi: 10.1016/j.nhtm.2014.12.002 (inactive 2024-11-02).{{cite journal}}: CS1 maint: DOI inactive as of November 2024 (link)
  12. ↑ Mahla RS (2016). "Stem Cells Applications in Regenerative Medicine and Disease Therapeutics". International Journal of Cell Biology. 2016 (7): 19. doi: 10.1155/2016/6940283 . PMC   4969512 . PMID   27516776.
  13. ↑ Woolf, Steven H. (9 January 2008). "What is Translational Science". JAMA. 299 (2). Tufts Clinical and Translational Science Institute: 211–213. doi:10.1001/jama.2007.26. PMID   18182604 . Retrieved 9 June 2015.
  14. ↑ Pober JS, Neuhauser CS, Pober JM (November 2001). "Obstacles facing translational research in academic medical centers". FASEB Journal. 15 (13): 2303–13. doi: 10.1096/fj.01-0540lsf . PMID   11689456. S2CID   32503545.
  15. ↑ Waldman, Scott A.; Terzic, Andre (2010-10-01). "Clinical and Translational Science: From Bench-Bedside to Global Village". Clinical and Translational Science. 3 (5): 254–257. doi:10.1111/j.1752-8062.2010.00227.x. ISSN   1752-8062. PMC   5439613 . PMID   20973923.
  16. ↑ "What is basic research?" (PDF). National Science Foundation. Retrieved 2014-05-31.
  17. ↑ Roll-Hansen N (April 2009). Why the distinction between basic (theoretical) and applied (practical) research is important in the politics of science (PDF) (Report). The London School of Economics and Political Science. Retrieved November 30, 2013.
  18. ↑ Cambrosio A, Keating P, Mercier S, Lewison G, Mogoutov A (December 2006). "Mapping the emergence and development of translational cancer research". European Journal of Cancer. 42 (18): 3140–8. doi:10.1016/j.ejca.2006.07.020. PMID   17079135.
  19. ↑ Tone, Andrea (2009). The Age of Anxiety: the History of America's Love Affairs with Tranquilizers.
  20. ↑ Ashutosh Jogalekar (November 26, 2012). "The perils of translational research". Scientific American Blog Network.
  21. ↑ Golde TE, Schneider LS, Koo EH (January 2011). "Anti-aβ therapeutics in Alzheimer's disease: the need for a paradigm shift". Neuron. 69 (2): 203–13. doi:10.1016/j.neuron.2011.01.002. PMC   3058906 . PMID   21262461.
  22. ↑ Prinz F, Schlange T, Asadullah K (August 2011). "Believe it or not: how much can we rely on published data on potential drug targets?". Nature Reviews. Drug Discovery. 10 (9): 712. doi: 10.1038/nrd3439-c1 . PMID   21892149.
  23. ↑ "Новости Мюнхена и Германии". CTSA Web.
  24. ↑ "Clinical and Translational Science Awards Program Hubs". www.ncats.nih.gov. National Institutes for Health. 13 March 2015. Retrieved 31 March 2016.
  25. ↑ The World's Largest Medical Center is Now Among the Most Energy Efficient | Department of Energy. Energy.gov (2011-05-18)
  26. ↑ "University of Rochester Clinical and Translational Science Institute". The University of Rochester.
  27. ↑ "Maine Medical Center Research Institute attracts top scientists, licenses discoveries". www.mainebiz.biz. Mainebiz. Retrieved 17 June 2015.
  28. ↑ "Translational Research Institute". www.scripps.edu. The Scripps Research Institute. Retrieved 17 June 2015.
  29. ↑ UC Davis Health System, Clinical and Translational Science Center. "UC Davis Clinical and Translational Science Center: About Us".
  30. ↑ "About Us | CTSI University of Pittsburgh".
  31. ↑ "Weill Cornell Clinical and Translational Science Center". Weill Cornell Medicine. 11 May 2023. Retrieved 11 May 2023.
  32. ↑ "Clinical & Translational Research Core". Wyss Institute at Harvard University. 10 May 2024. Retrieved 10 May 2024.
  33. ↑ "Translational Research – PhD and Graduate Certificate". www.med.monash.edu.au. Monash University. Retrieved 17 June 2015.
  34. ↑ "MPhil in Translational Research". www.di.uq.edu.au. University of Queensland Diamantina Institute. Retrieved 17 June 2015.
  35. ↑ "Clinical and Translational Research". medschool.duke.edu. Duke University. Retrieved 17 June 2015.
  36. ↑ "Center for Clinical and Translational Science". medschool.creighton.edu. Creighton University. Retrieved 14 July 2015.
  37. ↑ "Certificate Program in Translational". Emory University. Retrieved 4 Jan 2018.
  38. ↑ "PhD in Translational Health Sciences". smhs.gwu.edu. The George Washington University. Retrieved 9 June 2019.
  39. ↑ "Novartis". World Pharma News.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.